VACC

Vaccitech Share Price

14.68
-0.08 (-0.54%)
Upgrade to Real-Time
Afterhours (Closed)
14.68
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaccitech PLC VACC NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.08 -0.54% 14.68 00:00:07
Open Price Low Price High Price Close Price Prev Close
15.10 14.395 15.10 14.68 14.76
Bid Price Ask Price Spread News
13.85 16.65 2.80 - -
Trades Volume VWAP Dollar Volume Avg Volume
152 10,416  14.72  153,358 -
Last Trade Time Type Quantity Stock Price Currency
16:04:12 average 170  14.68 USD

Period:

Draw Mode:

Vaccitech PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 503.94M 34.33M 32.90M  4.82M  - -371.62 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - 3.06M 4.20%

more financials information »

News Vaccitech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

VACC Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.


Your Recent History
NASDAQ
VACC
Vaccitech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.